As of Mar 29
| +1.24 / +6.00%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 20.00, with a high estimate of 26.00 and a low estimate of 12.00. The median estimate represents a -8.63% decrease from the last price of 21.89.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.